论文部分内容阅读
Synergistic drug combinations have long been highly desired in treating complex disease of cancer.Yet,prioritizing synergistic agents from the large pool of potential combinatorial drugs is highly challenging.In-silico models are thus in urgent need to evaluate and prioritize the best candidate combinations.